From Emily Humpal <[email protected]>
Subject Time for Hospitals to Come Clean About Pricing
Date May 10, 2023 2:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI's Focus on Health Care

View this email in your browser ([link removed])
[link removed]
Time for Hospitals to Come Clean About Pricing

Newsmax | Sally Pipes
May 5, 2023

The Biden administration is cracking down on hospitals that keep their prices secret.

Under a policy announced last week, failing to abide by Trump-era hospital price transparency rules will no longer prompt a warning letter from the Centers for Medicare and Medicaid Services. Instead, hospitals will have 45 days to submit a Corrective Action Plan ([link removed]) for meeting these requirements — or face a fine.

Read more. . . ([link removed])

The Inflation Reduction Act Was Only the Beginning

Forbes | Wayne Winegarden
May 5, 2023

As it turns out, the fears that the Inflation Reduction Act (IRA) was simply another step toward a fully socialized healthcare system were well founded. For evidence, less than a year after the IRA was signed into law U.S. Senators Amy Klobuchar (D-MN), Peter Welch (D-VT) and 23 Democrat colleagues are now proposing another giant leap toward socialized medicine called the Strengthening Medicare and Reducing Taxpayer (SMART) Prices Act ([link removed]) .

Read more. . . ([link removed])

Small-Molecule Price Controls Are A Big Mistake

Forbes | Sally Pipes
May 8, 2023

The Biden administration is in the midst of setting the terms for its program of price controls on prescription drugs dispensed through Medicare. The first 10 medicines subject to the price caps will be selected by the end of this year ([link removed]) .

That prospect is already chilling investment in drug research, particularly in small-molecule drugs. This category of medicines, which are generally chemically synthesized, includes everything from aspirin to certain cancer drugs. The implications of this slowdown in research and development could be disastrous for patients.

Read more. . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2023 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
P.O. Box 60485 | Pasadena, CA 91116

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis